Select Medical (NYSE:SEM) Releases FY 2024 Earnings Guidance

Select Medical (NYSE:SEM) issued an update on its FY 2024 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 1.960-2.200 for the period, compared to the consensus estimate of 2.120. The company issued revenue guidance of $6.9 billion-$7.1 billion, compared to the consensus revenue estimate of $7.0 billion. Select Medical also updated its FY24 guidance to $1.96-2.20 EPS.

Select Medical Stock Performance

Shares of SEM stock traded down $5.00 during trading on Friday, reaching $34.18. 2,367,259 shares of the company’s stock were exchanged, compared to its average volume of 708,812. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 2.30. The stock has a market capitalization of $4.44 billion, a PE ratio of 16.28, a PEG ratio of 1.78 and a beta of 1.43. Select Medical has a twelve month low of $21.28 and a twelve month high of $40.50. The firm’s fifty day moving average price is $35.77 and its 200-day moving average price is $31.13.

Select Medical (NYSE:SEM) last issued its quarterly earnings data on Thursday, August 1st. The health services provider reported $0.60 EPS for the quarter, beating analysts’ consensus estimates of $0.59 by $0.01. Select Medical had a return on equity of 17.88% and a net margin of 3.91%. The firm had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.74 billion. During the same period in the prior year, the firm posted $0.61 EPS. The company’s revenue for the quarter was up 5.1% on a year-over-year basis. As a group, sell-side analysts anticipate that Select Medical will post 2.19 EPS for the current year.

Select Medical Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, August 30th. Stockholders of record on Wednesday, August 14th will be given a dividend of $0.125 per share. The ex-dividend date is Wednesday, August 14th. This represents a $0.50 dividend on an annualized basis and a dividend yield of 1.46%. Select Medical’s payout ratio is 23.81%.

Wall Street Analyst Weigh In

Several equities analysts have commented on the stock. Benchmark reissued a buy rating and issued a $48.00 target price on shares of Select Medical in a report on Friday. Royal Bank of Canada raised their target price on shares of Select Medical from $36.00 to $40.00 and gave the company an outperform rating in a report on Monday, May 6th. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of Moderate Buy and an average target price of $36.50.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.